| Primary |
| Drug Use For Unknown Indication |
55.8% |
| Product Used For Unknown Indication |
26.3% |
| Cytomegalovirus Infection |
3.2% |
| Infection |
3.2% |
| Pneumocystis Jiroveci Infection |
3.2% |
| Aortic Valve Replacement |
2.1% |
| Blood Culture Positive |
1.1% |
| Chronic Myelomonocytic Leukaemia |
1.1% |
| Cytomegalovirus Colitis |
1.1% |
| Cytomegalovirus Viraemia |
1.1% |
| Gastroenteritis Cryptosporidial |
1.1% |
| Oral Fungal Infection |
1.1% |
|
| Bone Marrow Failure |
14.8% |
| Thrombocytopenia |
11.1% |
| Drug Level Decreased |
7.4% |
| No Adverse Event |
7.4% |
| Aplasia |
3.7% |
| Arrhythmia |
3.7% |
| Bone Marrow Disorder |
3.7% |
| Cytolytic Hepatitis |
3.7% |
| Extravasation |
3.7% |
| Injection Site Oedema |
3.7% |
| Leukopenia |
3.7% |
| Liver Disorder |
3.7% |
| Lung Neoplasm Malignant |
3.7% |
| Neutropenia |
3.7% |
| Oedema |
3.7% |
| Pyramidal Tract Syndrome |
3.7% |
| Renal Failure |
3.7% |
| Renal Failure Acute |
3.7% |
| Sepsis |
3.7% |
| Septic Shock |
3.7% |
|
| Secondary |
| Product Used For Unknown Indication |
69.6% |
| Cytomegalovirus Infection |
6.9% |
| Aplasia |
3.1% |
| Drug Use For Unknown Indication |
2.3% |
| Acquired Immunodeficiency Syndrome |
2.0% |
| Gastrointestinal Candidiasis |
1.5% |
| Polymyositis |
1.5% |
| Diabetes Mellitus |
1.3% |
| Liver Transplant |
1.3% |
| Bone Marrow Conditioning Regimen |
1.0% |
| Cytomegalovirus Oesophagitis |
1.0% |
| Encephalitis Herpes |
1.0% |
| Human Herpesvirus 6 Infection |
1.0% |
| Lymphangitis |
1.0% |
| Oesophageal Candidiasis |
1.0% |
| Pneumocystis Jirovecii Pneumonia |
1.0% |
| Tuberculosis |
1.0% |
| Arrhythmia |
0.8% |
| Blood Culture Positive |
0.8% |
| Endocarditis |
0.8% |
|
| Toxic Epidermal Necrolysis |
17.9% |
| Thrombocytopenia |
14.3% |
| Cytolytic Hepatitis |
10.7% |
| Paraesthesia |
7.1% |
| Bone Marrow Failure |
5.4% |
| Stevens-johnson Syndrome |
5.4% |
| Tongue Oedema |
5.4% |
| Agranulocytosis |
3.6% |
| Bicytopenia |
3.6% |
| Blood Creatinine Increased |
3.6% |
| Gamma-glutamyltransferase Increased |
3.6% |
| Renal Failure Acute |
3.6% |
| Ventricular Arrhythmia |
3.6% |
| Aplasia |
1.8% |
| Bone Marrow Disorder |
1.8% |
| Bronchopulmonary Aspergillosis |
1.8% |
| Drug Eruption |
1.8% |
| Febrile Bone Marrow Aplasia |
1.8% |
| Histiocytosis Haematophagic |
1.8% |
| Hyponatraemia |
1.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.0% |
| Cytomegalovirus Infection |
10.7% |
| Hiv Infection |
6.6% |
| Prophylaxis Against Transplant Rejection |
6.6% |
| Prophylaxis |
5.5% |
| Renal Transplant |
4.8% |
| Crohn's Disease |
4.4% |
| Diverticulum |
4.4% |
| Thrombosis Prophylaxis |
3.7% |
| Pain |
3.3% |
| Product Used For Unknown Indication |
3.3% |
| Chronic Lymphocytic Leukaemia |
3.0% |
| Diabetes Mellitus |
3.0% |
| Osteoporosis |
3.0% |
| Bone Marrow Transplant |
2.6% |
| Lung Disorder |
2.6% |
| Diarrhoea |
2.2% |
| Graft Versus Host Disease |
2.2% |
| Insomnia |
2.2% |
| Gastrointestinal Candidiasis |
1.8% |
|
| Respiratory Failure |
12.8% |
| Thrombocytopenia |
10.3% |
| Septic Shock |
7.7% |
| Urinary Tract Infection |
7.7% |
| Graft Versus Host Disease |
5.1% |
| Hepatitis Toxic |
5.1% |
| Hypoacusis |
5.1% |
| Hypothermia |
5.1% |
| Pancytopenia |
5.1% |
| Toxic Epidermal Necrolysis |
5.1% |
| Transplant Rejection |
5.1% |
| Urinary Tract Infection Enterococcal |
5.1% |
| Asthenia |
2.6% |
| Cholestasis |
2.6% |
| Complications Of Transplanted Kidney |
2.6% |
| Confusional State |
2.6% |
| Cytolytic Hepatitis |
2.6% |
| Cytomegalovirus Infection |
2.6% |
| Death |
2.6% |
| Fanconi Syndrome |
2.6% |
|
| Interacting |
| Acute Lymphocytic Leukaemia |
100.0% |
|
| Renal Failure |
66.7% |
| Staphylococcal Infection |
33.3% |
|
